VA
EXAS

Vident Advisory’s Exact Sciences EXAS Stock Holding History

Vident Advisory’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,979
Closed -$506K – 1872
2025
Q4 		$506K Sell
4,979
-1,286
-21% -$103K ﹤0.01% 1164
2025
Q3 		$343K Sell
6,265
-590
-9% -$29.5K ﹤0.01% 1347
2025
Q2 		$364K Sell
6,855
-7,655
-53% -$389K ﹤0.01% 1212
2025
Q1 		$628K Sell
14,510
-7,937
-35% -$402K 0.01% 912
2024
Q4 		$1.26M Buy
22,447
+4,110
+22% +$256K 0.02% 558
2024
Q3 		$1.25M Buy
18,337
+4,589
+33% +$259K 0.03% 547
2024
Q2 		$581K Sell
13,748
-1,648
-11% -$90.7K 0.02% 809
2024
Q1 		$1.06M Sell
15,396
-12,781
-45% -$808K 0.02% 554
2023
Q4 		$2.08M Sell
28,177
-29
-0.1% -$1.9K 0.05% 369
2023
Q3 		$1.92M Buy
+28,206
New +$2.39M 0.06% 319

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Vident Advisory's EXAS Position: Q1 2026 in Review

Vident Advisory sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 4,979 shares — an estimated $506K sold.

Vident Advisory first reported a position in EXAS in Q3 2023 and held it in 10 quarters. The position peaked at $2.08M in Q4 2023. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Vident Advisory reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Vident Advisory sold 4,979 Exact Sciences shares in Q1 2026, an estimated $506K.
  • Vident Advisory first reported a position in Exact Sciences in Q3 2023 and held it in 10 quarters.
  • Vident Advisory's Exact Sciences position peaked at $2.08M in Q4 2023.
  • 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.